RPG Life Sciences, an RPG Group company, today said it has clocked a 63 per cent growth in PAT to Rs 10.80 crore in FY'10 compared to Rs 6.61 crore in the previous year.
Net sales stood at Rs 159.85 crore in FY'10 against Rs 140.47 crore in the previous year, translating into a growth of 14 per cent, a press release issued here said.
In Q4, FY'10, the company's net sales stood at Rs 44.39 crore against Rs 31.70 crore in the corresponding quarter last year, a growth of 40 per cent.
PAT grew to Rs 3.74 crore during the January-March period from Rs 0.36 crore in the corresponding quarter of the previous year, the release said.
The company has recommended a dividend of Rs 1.44 per share (18 per cent) for FY'10.
"The company has performed really well and we are confident of maintaining the growth momentum in the year ahead," RPG Life Sciences Managing Director Ajit Singh Chouhan said.
RPG Life Sciences is an important player in the formulations, bulk drugs and bio-tech business and has a presence in both domestic and international markets.
